“…Glial cells expressing the proteoglycan NG2 are abundantly distributed in white and gray matter areas of the developing and adult brain, where they make up 5-10% of all glia and are heterogeneous with regard to their antigen profile (Degen et al, 2012;Moshrefi-Ravasdjani et al, 2017;Trotter, Karram, & Nishiyama, 2010). They sustain the capacity to proliferate and differentiate throughout life and constitute therefore the largest proliferative cell population outside the adult neurogenic niches in the CNS (Dawson, Polito, Levine, & Reynolds, 2003;Moshrefi-Ravasdjani et al, 2017). Fate mapping studies revealed that in the postnatal white matter, NG2 glial cells mainly differentiate into myelinating oligodendrocytes (Dimou, Simon, Kirchhoff, Takebayashi, & Götz, 2008;Kang, Fukaya, Yang, Rothstein, & Bergles, 2010;Zhu et al, 2011;Zhu, Bergles, & Nishiyama, 2008), a process that is enhanced following demyelination, CNS injury, and in chronic neurodegenerative disease (Kang et al, 2010;Levine & Reynolds, 1999;Magnus et al, 2008;McTigue, Wei, & Stokes, 2001).…”